Artiva Biotherapeutics, Inc. 10-K filing
Filed 2026-03-10 · Report date 2025-12-31 · 2025 FY
Filing metadata
- Accession number
- 0001193125-26-100135
- Form type
- 10-K
- CIK
- 0001817241
- Primary document
- https://www.sec.gov/Archives/edgar/data/1817241/000119312526100135/artv-20251231.htm
Extracted primary information
This filing includes deterministic financial metrics extracted from public filing data for Artiva Biotherapeutics, Inc..
Reported financial metrics
| Metric | Current | Prior | Change |
|---|---|---|---|
| Revenue | $0 | - | - |
| Operating Income | $-89.8M | - | - |
| Net Income | $-83.9M | - | - |
| Eps Basic | -3.43 | - | - |
| Eps Diluted | -3.43 | - | - |
| Cash And Equivalents | $26.7M | - | - |
| Total Assets | $130.9M | - | - |
| Total Liabilities | $21.0M | - | - |
| Shareholders Equity | $110.0M | - | - |
| Operating Cash Flow | $-76.8M | - | - |
| Capital Expenditures | $2.6M | - | - |